# Prelude Therapeutics Inc: Form 8-K, filed Mar 28, 2025

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: 8-K
- Filed: 2025-03-28
- Accepted by EDGAR: Mar 28, 2025, 16:30 ET
- Period: 2025-03-27
- Accession: 0000950170-25-046839
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000095017025046839/prld-20250327.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000095017025046839/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000095017025046839/prld-20250327.htm

Filed Mar 28, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-046839. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
